Impact of prediabetes on postoperative outcomes following short-segment transforaminal lumbar interbody fusions

糖尿病前期对短节段经椎间孔腰椎椎体间融合术后结果的影响

阅读:1

Abstract

OBJECTIVES: Type 2 diabetes mellitus (T2DM) is a well-established risk factor for adverse surgical outcomes, but the impact of prediabetes on spine surgery remains unexplored. This study evaluated the influence of prediabetes on postoperative complications in patients undergoing short-segment (≤3 levels) transforaminal lumbar interbody fusion (TLIF). METHODS: We retrospectively reviewed patients undergoing 1-3 level TLIF in a national administrative database. Patients were categorized into 3 groups: no diabetes, prediabetes, and T2DM. Patients with type 1 diabetes were excluded. A 1:1:1 exact match was performed to balance demographics, comorbidities, and the number of spinal levels fused. Thirty-day postoperative medical and surgical complications were analyzed. RESULTS: A total of 17,796 patients (5,932 per group) were included. Patients with T2DM demonstrated a significantly higher incidence of urinary tract infection (OR, 1.49; 97.5% CI, 1.19-1.86), pneumonia (OR, 1.59; 97.5% CI, 1.10-2.31), acute kidney injury (OR, 2.32; 97.5% CI, 1.70-3.18), surgical site infection (OR, 1.34; 97.5% CI, 1.04-1.74), overall medical complications (OR, 1.50; 97.5% CI, 1.28-1.75), and surgical complications (OR, 1.29; 97.5% CI, 1.05-1.58). In contrast, patients with prediabetes did not demonstrate a statistically significant increase in postoperative complications. CONCLUSIONS: T2DM is associated with a higher risk of medical and surgical complications following short-segment TLIF. However, prediabetes does not appear to affect postoperative complication rates. These findings suggest enhanced perioperative management is warranted for patients with T2DM, while standard protocols may be sufficient for patients with prediabetes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。